FDA Grants De Novo Authorization to 5-Year Breast Cancer Risk Prediction Device

Source: Pharmacy Times articles

Clarity Breast’s FDA-approved AI platform revolutionizes breast cancer risk prediction, enhancing early detection and personalized prevention strategies.
Read More